NDC 43975-315

Bexarotene

Bexarotene

Bexarotene is a Oral Capsule, Liquid Filled in the Human Prescription Drug category. It is labeled and distributed by Amerigen Pharmaceuticals Inc.. The primary component is Bexarotene.

Product ID43975-315_03f1beb6-af05-4787-8eb4-61f1d0298122
NDC43975-315
Product TypeHuman Prescription Drug
Proprietary NameBexarotene
Generic NameBexarotene
Dosage FormCapsule, Liquid Filled
Route of AdministrationORAL
Marketing Start Date2018-05-10
Marketing CategoryANDA / ANDA
Application NumberANDA209861
Labeler NameAmerigen Pharmaceuticals Inc.
Substance NameBEXAROTENE
Active Ingredient Strength75 mg/1
Pharm ClassesRetinoid [EPC],Retinoids [CS]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 43975-315-10

100 CAPSULE, LIQUID FILLED in 1 BOTTLE (43975-315-10)
Marketing Start Date2018-05-10
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 43975-315-10 [43975031510]

Bexarotene CAPSULE, LIQUID FILLED
Marketing CategoryANDA
Application NumberANDA209861
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-05-10

Drug Details

Active Ingredients

IngredientStrength
BEXAROTENE75 mg/1

OpenFDA Data

SPL SET ID:e713c60d-f623-4260-b0ca-db07e1365fd2
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 308725
  • Pharmacological Class

    • Retinoid [EPC]
    • Retinoids [CS]

    NDC Crossover Matching brand name "Bexarotene" or generic name "Bexarotene"

    NDCBrand NameGeneric Name
    0054-0399Bexarotenebexarotene
    0378-6955BexaroteneBexarotene
    0591-2832bexarotenebexarotene
    0832-0285BexaroteneBexarotene
    42292-007BexaroteneBexarotene
    43975-315BexaroteneBexarotene
    68682-002bexarotenebexarotene
    68682-003bexarotenebexarotene
    69238-1250BexaroteneBexarotene
    69238-2088BexaroteneBexarotene
    0187-5525Targretinbexarotene
    0187-5526Targretinbexarotene

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.